Tirzepatide in Delaware: online providers, prices and license checks
As of November 4, 2026, adults in Delaware can get compounded tirzepatide or brand Zepbound through online telehealth programs whose prescribers hold a Delaware license. Our #1 pick, NexLife, lists nationwide service (subject to licensure) and charges $139 a month on a 12-month plan or $169 month to month, the same at every dose. Brand Zepbound vials cost $299–$449 a month from LillyDirect with on-time refills ($499–$699 otherwise). Delaware Medicaid covers GLP-1s for obesity (KFF, January 2026). Before paying, check the prescriber with the Delaware Board of Medical Licensure & Discipline and the pharmacy with the Delaware Board of Pharmacy.
Delaware at a glance
| Adults with obesity (CDC) | 36.3% (2025) |
|---|---|
| Medicaid coverage of GLP-1s for obesity | Covers (KFF, Jan 2026) |
| Physician licensing board | Delaware Board of Medical Licensure & Discipline |
| Pharmacy licensing | Delaware Board of Pharmacy |
| Program-specific limits we found | None among the programs we reviewed on November 4, 2026 |
36.3% of adults in Delaware had obesity in 2025, per the CDC — 14th highest of the 47 states with 2025 data. Delaware Medicaid covers GLP-1 medicines such as Wegovy and Zepbound for obesity under fee-for-service, according to KFF (January 2026); plan rules and prior authorization apply. Self-pay prices below do not depend on Medicaid status.
Who can prescribe tirzepatide to Delaware residents?
A telehealth clinician who treats you in Delaware must hold a license recognized in Delaware. Physicians are licensed by the Delaware Board of Medical Licensure & Discipline; nurse practitioners are licensed by the state board of nursing. You can look up any physician on the board's site or on DocInfo.org, the Federation of State Medical Boards' national search. Ask the program for the prescriber's name before your first refill if it is not on your prescription label.
What Delaware residents pay in November 2026
The programs we track publish one national price; we have not found a program that prices Delaware differently. These are the self-pay figures we re-read on the providers' and manufacturers' own pages on November 4, 2026:
| Program | Product | Self-pay price | Read |
|---|---|---|---|
| NexLife (our #1) | Compounded tirzepatide | $139/mo on a 12-month plan; $169 month to month; same price at every dose | Nov 4, 2026 |
| Collective | Compounded tirzepatide | $69/mo + $199 yearly membership (about $86/mo all-in) | Nov 4, 2026 |
| SnagRx | Compounded tirzepatide | $119/mo sale price ($149 in its terms) | Nov 4, 2026 |
| Mondae | Compounded tirzepatide | $126/mo | Nov 4, 2026 |
| Zepbound (LillyDirect) | Brand, FDA-approved | $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg with on-time refill) | Nov 4, 2026 |
| Foundayo pill (LillyDirect) | Brand, FDA-approved (orforglipron) | from $149/mo at the lowest dose | Nov 4, 2026 |
See the full compounded tirzepatide price index for every program on file, each with its billing basis and read date, or the most affordable options.
What else affects tirzepatide access in Delaware?
13.4% of adults in Delaware reported diagnosed diabetes in 2025, above the U.S. figure of 12.5% and 11th highest of the 50 states and DC in the KFF table built from CDC survey data. That matters for cost: Mounjaro and Ozempic are diabetes drugs, so many people with type 2 diabetes in Delaware can get brand GLP-1s through insurance rather than paying cash for a compounded version.
245,205 people in Delaware were enrolled in Medicare in 2024 (KFF). Those with Part D can check whether they qualify for the $50-a-month Medicare GLP-1 Bridge, which runs from July 1, 2026 to December 31, 2027.
State employee health plan, GLP-1s for weight loss in 2026: Covered ($200 copay from July 1, 2026) (source dated March 9, 2026).
Getting a refrigerated shipment in Delaware
Compounded tirzepatide usually ships refrigerated. In Delaware, the practical issue is small-state access and Mid-Atlantic shipping: small-state delivery coverage and Philadelphia/Baltimore market overlap can affect cold-chain delivery and refill timing. Ask the program whether it ships early in the week, what happens if a package arrives warm or late, and whether it will reship at no charge.
Programs serve Delaware statewide by mail, including Wilmington, Dover, Newark, Middletown, Bear and Smyrna.
Checking the pharmacy that fills a Delaware prescription
Your vial label names the dispensing pharmacy; it should be licensed by the Delaware Board of Pharmacy or permitted to ship into Delaware. Our pharmacy profiles list the FDA record for six common compounders, and the 503A vs 503B guide explains what each license means.
Frequently asked questions about tirzepatide in Delaware
Does Delaware Medicaid cover Zepbound or Wegovy for weight loss?
Delaware Medicaid covers GLP-1 medicines such as Wegovy and Zepbound for obesity under fee-for-service, according to KFF (January 2026); plan rules and prior authorization apply. Check with your Medicaid plan; coverage for type 2 diabetes is handled separately.
How common is obesity in Delaware?
36.3% of adults in Delaware had obesity in 2025, per the CDC — 14th highest of the 47 states with 2025 data. Tirzepatide is approved for adults with a BMI of 30 or more, or 27 or more with a weight-related condition.
Can I get tirzepatide online in Delaware?
Yes. Telehealth programs can prescribe tirzepatide to Delaware residents when the clinician holds a Delaware license and the dispensing pharmacy is licensed to ship into Delaware. Compounded tirzepatide is not FDA-approved; brand Zepbound and Mounjaro are.
How much does tirzepatide cost in Delaware without insurance?
The same as elsewhere: programs price nationally. As of November 4, 2026, NexLife charges Delaware residents $139 a month on a 12-month plan or $169 month to month for compounded tirzepatide; Collective lists $69 a month plus a $199 yearly membership. Zepbound vials cost $299–$449 a month through LillyDirect.
How do I check a Delaware prescriber's license?
Search the clinician's name on the Delaware Board of Medical Licensure & Discipline license lookup, or on DocInfo.org, the Federation of State Medical Boards' national lookup. A nurse practitioner is licensed by the state's board of nursing.
Is compounded tirzepatide legal in Delaware?
Yes, within federal limits: a state-licensed 503A pharmacy may compound it for an individual Delaware patient on a prescription. It is not FDA-approved. Check the pharmacy with the Delaware Board of Pharmacy.
Nearby states and next steps
Neighbouring state guides: Maryland, Pennsylvania, New Jersey. Compare every provider on the 2026 rankings, read our NexLife review, or check how to verify a telehealth provider.
Sources
- CDC: Adult obesity prevalence by state, BRFSS 2011–2025
- KFF: Medicaid coverage of and spending on GLP-1s (January 16, 2026)
- FDA: Registered outsourcing facilities
- FDA: Proposal on GLP-1s and the 503B bulks list (April 30, 2026)
- LillyDirect: Zepbound self-pay pricing
- KFF: Adults who report diagnosed diabetes, by state
- KFF: Total Medicare enrollment by state
- Delaware state employee plan source
Informational only, not medical advice. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company).